207 related articles for article (PubMed ID: 2530281)
1. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
[TBL] [Abstract][Full Text] [Related]
2. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
[TBL] [Abstract][Full Text] [Related]
3. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
[TBL] [Abstract][Full Text] [Related]
4. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
5. Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18.
Mouzaki A; Volk HD; Osawa H; Diamantstein T
Eur J Immunol; 1987 Mar; 17(3):335-41. PubMed ID: 3106058
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia.
Ueda H; Hancock WW; Cheung YC; Tanaka K; Kupiec-Weglinski JW; Tilney NL
Transplantation; 1990 Jun; 49(6):1124-9. PubMed ID: 2113725
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
[TBL] [Abstract][Full Text] [Related]
8. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
Carteron NL; Schimenti CL; Wofsy D
J Immunol; 1989 Mar; 142(5):1470-5. PubMed ID: 2521880
[TBL] [Abstract][Full Text] [Related]
9. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
[TBL] [Abstract][Full Text] [Related]
10. Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
Tanaka K; Turka LA; Kupiec-Weglinski JW; Milford EL; Ueda H; Diamantstein T; Carpenter CB; Tilney NL
Transplantation; 1990 Jul; 50(1):125-31. PubMed ID: 2142344
[TBL] [Abstract][Full Text] [Related]
11. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
Tinubu SA; Hakimi J; Kondas JA; Bailon P; Familletti PC; Spence C; Crittenden MD; Parenteau GL; Dirbas FM; Tsudo M
J Immunol; 1994 Nov; 153(9):4330-8. PubMed ID: 7930631
[TBL] [Abstract][Full Text] [Related]
12. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW
Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
Kupiec-Weglinski JW; Mariani G; Tanaka K; Di Stefano R; Stünkel KG; Diamantstein T; Tilney NL
Cell Immunol; 1989 Oct; 123(1):148-57. PubMed ID: 2476241
[TBL] [Abstract][Full Text] [Related]
15. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Tanaka K; Kupiec-Weglinski JW; Hancock WW; Stunkel K; Diamantstein T; Tilney NL
Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532
[No Abstract] [Full Text] [Related]
17. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.
Gutstein NL; Wofsy D
J Immunol; 1986 Dec; 137(11):3414-9. PubMed ID: 3097122
[TBL] [Abstract][Full Text] [Related]
18. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
Wasfie T; Reed E; Suciu-Foca N; Hardy MA
Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
[TBL] [Abstract][Full Text] [Related]
19. Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies.
Mouzaki A; Diamantstein T
Eur J Immunol; 1987 Nov; 17(11):1661-4. PubMed ID: 2445587
[TBL] [Abstract][Full Text] [Related]
20. Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
Kupiec-Weglinski JW; Tilney NL; Stunkel KG; Grutzmann R; van der Meide PH; Di Stefano R; Diamantstein T
Transplantation; 1989 Jan; 47(1):11-6. PubMed ID: 2463699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
